Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Aarhus University Hospital
University of Oklahoma
Werewolf Therapeutics, Inc.
Martini-Klinik am UKE GmbH
Tyra Biosciences, Inc
Hoffmann-La Roche
University Health Network, Toronto
University of Wisconsin, Madison
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Changzheng Hospital
M.D. Anderson Cancer Center
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Eli Lilly and Company
AstraZeneca
AstraZeneca
Carisma Therapeutics Inc
University Hospital, Ghent
Movember Foundation
Actuate Therapeutics Inc.
Salubris Biotherapeutics Inc
Adaptimmune
National University Hospital, Singapore